1 Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
2 Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Public Health Rep. 2018 Jul/Aug;133(4):423-431. doi: 10.1177/0033354918774330. Epub 2018 Jun 27.
A complete and accurate count of the number of opioid-related overdose deaths is essential to properly allocate resources. We determined the rate of unintentional overdose deaths (non-opioid-related, opioid-related, or unspecified) in the United States and by state from 1999 to 2015 and the possible effects of underreporting on national estimates of opioid abuse.
We abstracted unintentional drug overdose deaths ( International Classification of Diseases, 10th Revision, codes X40-X44) with contributory drug-specific T codes (T36.0-T50.9) from the Mortality Multiple Cause Micro-Data Files. We assumed that the proportion of unspecified overdose deaths that might be attributed to opioids would be the same as the proportion of opioid-related overdose deaths among all overdose deaths and calculated the number of deaths that could be reallocated as opioid-related for each state and year. We then added these reallocated deaths to the reported deaths to determine their potential effect on total opioid-related deaths.
From 1999 to 2015, a total of 438 607 people died from unintentional drug overdoses. Opioid-related overdose deaths rose 401% (from 5868 to 29 383), non-opioid-related overdose deaths rose 150% (from 3005 to 7505), and unspecified overdose deaths rose 220% (from 2255 to 29 383). In 5 states (Alabama, Indiana, Louisiana, Mississippi, and Pennsylvania), more than 35% of unintentional overdose deaths were coded as unspecified. Our reallocation resulted in classifying more than 70 000 unspecified overdose deaths as potential additional opioid-related overdose deaths.
States may be greatly underestimating the effect of opioid-related overdose deaths because of incomplete cause-of-death reporting, indicating that the current opioid overdose epidemic may be worse than it appears.
准确统计阿片类药物过量死亡人数对于合理分配资源至关重要。我们旨在确定 1999 年至 2015 年美国及各州非阿片类药物相关、阿片类药物相关或未指明原因的药物意外过量死亡率,并评估报告不足对阿片类药物滥用国家估计值的可能影响。
我们从死亡原因多重原因微观数据文件中提取国际疾病分类第 10 版(ICD-10)编码 X40-X44 的非故意药物过量死亡(药物特异性 T 编码 T36.0-T50.9 作为促成因素)。我们假设,未指明原因的过量死亡中归因于阿片类药物的比例与所有过量死亡中阿片类药物相关过量死亡的比例相同,并计算各州每年可重新分配为阿片类药物相关的死亡人数。然后,我们将这些重新分配的死亡人数添加到报告的死亡人数中,以确定它们对总阿片类药物相关死亡人数的潜在影响。
1999 年至 2015 年,共有 438607 人死于非故意药物过量。阿片类药物相关过量死亡人数增加了 401%(从 5868 例增加到 29383 例),非阿片类药物相关过量死亡人数增加了 150%(从 3005 例增加到 7505 例),未指明原因的过量死亡人数增加了 220%(从 2255 例增加到 29383 例)。在 5 个州(阿拉巴马州、印第安纳州、路易斯安那州、密西西比州和宾夕法尼亚州),超过 35%的非故意药物过量死亡被编码为未指明原因。我们的重新分配导致超过 70000 例未指明原因的过量死亡被归类为潜在的额外阿片类药物相关过量死亡。
由于死因报告不完整,各州可能严重低估了阿片类药物相关过量死亡的影响,这表明当前的阿片类药物过量流行可能比实际情况更为严重。